|
THE GOVERNMENT OF CANADA INVESTS $3M IN OILSEED RESEARCH THETFORD MINES, Quebec, August 29, 2008 – The Honourable Christian Paradis, Minister of Public Works and Government Services, Secretary of State (Agriculture) and MP for Mégantic–L’Érable, today announced that the Government of Canada is contributing $3 million in funding to the Industrial Oil Seed Network (IOSN) under the Agricultural Bioproducts Innovation Program (ABIP). Read more LifeSciences British Columbia Adds Three Industry Leaders to their Board of Directors For Immediate Release – September 24, 2008 Vancouver – LifeSciences BC today announced the appointment of three new Board members representing leading life sciences companies in British Columbia. Mr. Ian Thompson, President, Canadian BioEnergy was appointed as of the September 16th Board of Directors’ meeting, and Dr. Steven Gillis, Managing Director, ARCH Venture Partners; and Mr. Gordon MacCauley, President & Chief Executive Officer, Allon Therapeutics were elected to LifeSciences BC’s Board of Directors at yesterday’s Annual General Meeting. Dr. Robert Sindelar of UBC was also re-elected to the Board of Directors. Read more Inimex Pharmaceuticals Honored Among This Year's Most Promising Private Technology Ventures in Canada C-Level Executives and Venture Capital Leaders Join for Second AnnualRed Herring Canada Conference in Mont-Tremblant, Quebec Vancouver, BC, Sept. 15, 2008 -- Inimex Pharmaceuticals is pleased to announce that it has been named as one of the finalists of the "Red Herring Top 50 Canada" award, a prestigious list honoring this year’s most promising private technology ventures in Canada. Red Herring Canada will provide an opportunity for the Top 50 companies to deliver their message at the Red Herring Canada Conference in Mont-Tremblant, Quebec, September 15 to 17, 2008. Read more iCo Therapeutics Selected as Canada's Top 10™ Competition Winner For Immediate Release - October 1, 2008 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO), a reprofiling company focused on redosing or reformulating drugs with clinical history for new or expanded indications, is pleased to announce that iCo has been selected as one of Canada's Top 10™ Competition winners. Top 10™ winners are chosen by an independent expert panel of Canadian and U.S. venture capitalists. Read more Cobalt Engineering Clients Recognized by BC Hydro Power Smart Vancouver – Cobalt Engineering LLP is pleased to announce that their clients’ projects, Discovery Parks Trust and Kwantlen Polytechnic University, have won the 2008 BC Hydro Power Smart Excellence Awards. The Power Smart Excellence Awards showcase the best energy-efficiency and conservation practices of BC Hydro customers. In collaboration with Cobalt, Discovery Parks Trust and Kwantlen Polytechnic University have integrated continuous energy management into their operations. While Discovery Parks Trust won in the category of Innovation in Sustainable Building Design, Kwantlen Polytechnic University received the award for Excellence in Energy Management. “As a fully integrated design firm, we are honoured and proud of our work for Discovery Parks Trust and Kwantlen Polytechnic University. The management and staff are pleased to continue our commitment to sustainability,” said Edward Smith, Cobalt’s CEO. Read more Why Clean Tech Is Taking Biotech's Shine It's simple: Alternative energy is where the venture capital is these days. Plus, the skill sets are similar, and researchers are making the jump by Connie Johnson Hambley Nigel Beeley is a biopharma veteran. He spent 25 years in research at such biotechnology companies as Amylin Pharmaceuticals (AMLN), Arena Pharmaceuticals (ARNA), and Senomyx (SNMX). He had a hand in creating cancer and metabolic disease drugs Mylotarg, Symlin, Byetta, and Lorcaserin. But when he decided to start his own company based on pharmaceutical discoveries, he made a switch to a field many might find surprising: emerging alternative energy. Read more
PROOF Centre of Excellence affirms strong leadership OCTOBER 16, 2008FOR IMMEDIATE RELEASE VANCOUVER, BC – The Centre of Excellence for the Prevention of Organ Failure (PROOF) is delighted to announce the appointments of Dr. George Schreiner as Chairman of the Board of Directors and Ms. Marjorie Co as Chief Development Officer. Read more BC Advantage Funds Announces Advantage Growth Fund Nov 04, 2008 16:39 ET VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 4, 2008) - BC Advantage Funds announced today that it will change the name and investment focus of its Advantage Life Sciences Fund II to focus on investments in emerging BC-based growth companies. The name of the fund will change to the Advantage Growth Fund. Read more AMGEN OFFERS $10,000 SCIENCE TEACHING AWARD, CALLS FOR TEACHERS TO APPLY AMGEN Expands Award for Science Teaching Excellence (AASTE) to Recognize Outstanding Teachers in Four Provinces MISSISSAUGA, ON. (Nov. 1, 2008) – Amgen Canada today announced that applications for the Amgen Award for Science Teaching Excellence (AASTE) are now open and is encouraging teachers in BC, Alberta, Ontario and Quebec to apply. The AASTE is designed to recognize and honour teachers who demonstrate exemplary science teaching and who achieve demonstrated results in student learning at the K-12 level in Canada. Read more TRIUMF: Vancouver Scientists Help Solve World Isotope Dilemma Vancouver scientists help solve world isotope dilemma Intense beams of light may be able to generate material for nuclear medicine Margaret Munro, Canwest News Service Published: Monday, November 17, 2008 Vancouver-based scientists are at the forefront of a team who say they have hit on "a uniquely Canadian solution" to the world's medical isotopes woes. The team, which includes scientists from Triumf, the national particle and nuclear physics laboratory at the University of B.C., say intense beams of light should be able to generate isotopes for nuclear medicine. Read more Download the Radiotracer whitepaper Download the Neutrinos whitepaper For additional news on the bioproducts and bioenergy sector, please visit our page. |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |